Oruka Therapeutics, Inc. (ORKA) ownership: Top institutional holder: FMR LLC ($364.51M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| FMR LLC | 7431403.00 | $364.51M | 2026-03-31 |
| Venrock Adviser, LLC | 4148428.00 | $203.48M | 2026-03-31 |
| Fairmount Funds Management LLC | 3705262.00 | $181.74M | 2026-03-31 |
| BlackRock, Inc. | 3527087.00 | $173.00M | 2026-03-31 |
| VIKING GLOBAL INVESTORS LP | 2666690.00 | $130.80M | 2026-03-31 |
| Paradigm Biocapital Advisors LP | 2320316.00 | $113.81M | 2026-03-31 |
| RTW INVESTMENTS, LP | 2058148.00 | $100.95M | 2026-03-31 |
| Deep Track Capital, LP | 2034203.00 | $99.78M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 |
Back to ORKA overview · ORKA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.